Beyer M, Gimsa U, Eyupoglu IY, et al. Phagocytosis of neuronal or glial debris by microglial cells: upregulation of MHC class II expression and multinuclear giant cell formation in vitro[J]. Glia, 2000,31(3): 262-266.
[2]
Walker DG, Whetzel AM, Lue LF. Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microglia[J]. Neuroscience, 2014. [Epub ahead of print]
[3]
Steel CD, Breving K, Tavakoli S, et al. Role of peripheral immune response in microglia activation and regulation of brain chemokine and proinflammatory cytokine responses induced during VSV encephalitis[J]. J Neuroimmunol, 2014,267(1-2): 50-60.
[4]
Fernandes A, Miller-Fleming L, Pais TF. Microglia and inflammation: conspiracy, controversy or control?[J]. Cell Mol Life Sci, 2014, 71(20): 3969-3985.
[5]
Hausler KG, Prinz M, Nolte C, et al. Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages[J]. Eur J Neurosci, 2002,16(11): 2113-2122.
[6]
Hanisch UK.Microglia as a source and target of cytokines[J]. Glia, 2002,40(2): 140-155.
[7]
Block ML , Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism[J]. Prog Neurobiol, 2005,76(2): 77-98.
[8]
Garden GA , Moller T. Microglia biology in health and disease[J]. J Neuroimmune Pharmacol, 2006,1(2): 127-137.
[9]
de Pablos RM, Herrera AJ, Espinosa-Oliva AM, et al. Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation[J]. J Neuroinflammation, 2014,11: 34.
[10]
Lopez-Collazo E , del Fresno C. Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences[J]. Crit Care, 2013,17(6): 242.
[11]
Leung PY, Packard AE, Stenzel-Poore MP.It's all in the family: multiple Toll-like receptors offer promise as novel therapeutic targets for stroke neuroprotection[J]. Future Neurol, 2009,4(2): 201-208.
[12]
Virca GD, Kim SY, Glaser KB, et al. Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells[J]. J Biol Chem, 1989, 264(36): 21951-21956.
[13]
Simon RP, Niiro M, Gwinn R. Prior ischemic stress protects against experimental stroke[J]. Neurosci Lett, 1993,163(2): 135-137.
[14]
Buenafe AC , Bourdette DN.Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis[J]. J Neuroimmunol, 2007,182(1-2): 32-40.
[15]
Marsh B, Stevens SL, Packard AE, et al. Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3[J]. J Neurosci, 2009,29(31): 9839-9849.
[16]
Floden AM , Combs CK. Microglia repetitively isolated from in vitro mixed glial cultures retain their initial phenotype[J]. J Neurosci Methods, 2007,164(2): 218-224.
Lin HY, Huang CC,Chang KF.Lipopolysaccharide preconditioning reduces neuroinflammation against hypoxic ischemia and provides long-term outcome of neuroprotection in neonatal rat[J]. Pediatr Res, 2009, 66(3): 254-259.
[19]
Marsh BJ, Williams-Karnesky RL, Stenzel-Poore MP.Toll-like receptor signaling in endogenous neuroprotection and stroke[J]. Neuroscience, 2009, 158(3): 1007-1020.
[20]
Bahjat FR, Williams-Karnesky RL, Kohama SG, et al. Proof of concept: pharmacological preconditioning with a Toll-like receptor agonist protects against cerebrovascular injury in a primate model of stroke[J]. J Cereb Blood Flow Metab, 2011, 31(5): 1229-1242.
[21]
Marsh BJ , Stenzel-Poore MP. Toll-like receptors: novel pharmacological targets for the treatment of neurological diseases[J]. Curr Opin Pharmacol, 2008,8(1): 8-13.
[22]
Kumral A, Tuzun F, Ozbal S, et al. Lipopolysaccharide-preconditioning protects against endotoxin-induced white matter injury in the neonatal rat brain[J]. Brain Res, 2012, 1489: 81-89.
[23]
Rosenzweig HL, Minami M, Lessov NS, et al . Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance[J]. J Cereb Blood Flow Metab, 2007, 27(10): 1663-1674.
[24]
Hanisch UK, Johnson TV, Kipnis J.Toll-like receptors: roles in neuroprotection? [J].Trends Neurosci, 2008, 31(4): 176-182.
[25]
Bohannon JK, Hernandez A, Enkhbaatar P, et al. The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants[J]. Shock, 2013,40(6): 451-462.
[26]
Schaafsma W, Zhang X, van Zomeren KC, et al. Long-lasting pro-inflammatory suppression of microglia by LPS-preconditioning is mediated by RelB-dependent epigenetic silencing[J]. Brain Behav Immun, 2015. [Epub ahead of print]
